Farmácia/Notícias da Indústria

Qual é o futuro das vacinas em relação aos raros distúrbios de coagulação? O jornal Science analisa as descobertas mais recentes.

5 Mai, 2021 | 09:37h

What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest – Science

---

Covax: Como as vacinas contra Covid serão distribuídas pelo mundo?

5 Mai, 2021 | 09:36h

Covax: How will Covid vaccines be shared around the world? – BBC

Relacionado: WHO chief – The world can bring the global COVID-19 pandemic under control in the coming months provided it distributes the necessary resources fairly E A year in the COVID-19 vaccine scheme COVAX

---

Vacinas chinesas contra COVID estão se tornando globais – mas ainda há questões.

5 Mai, 2021 | 09:32h

China’s COVID vaccines are going global — but questions remain – Nature

---

Diretriz Preliminar da USPSTF: Evidência insuficiente para recomendar suplementos multivitamínicos para prevenção de DCV ou câncer. A diretriz também recomenda não usar betacaroteno (risco aumentado de morte por DCV e câncer de pulmão) ou vitamina E (evidência clara de ausência de benefício).

5 Mai, 2021 | 09:31h

Draft Recommendation Statement: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer – U.S. Preventive Services Task Force

Revisão Preliminar da Evidência: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer

---

Atualização de Diretriz ASCO: Dosagem adequada de terapia sistêmica para pacientes adultos obesos com câncer.

5 Mai, 2021 | 09:26h

Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update – Journal of Clinical Oncology

---

Infecção prévia por SARS-Cov-2 gera resposta às variantes após a primeira dose de vacina

4 Mai, 2021 | 10:10h

Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose – Imperial College London

Estudo Original: Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose – Science

 

Comentário no Twitter (fio – clique para saber mais)

Just published @ScienceMagazine
"After one dose, individuals with *prior infection* showed enhanced T cell immunity, antibody secreting memory B cell response to spike and neutralizing antibodies effective against B.1.1.7 and B.1.351." 👍https://t.co/7cCVM6iqdP pic.twitter.com/GiC43bjwZZ

— Eric Topol (@EricTopol) April 30, 2021

 

---

OMS lista vacina do laboratório Moderna para uso emergencial

4 Mai, 2021 | 10:08h

WHO lists Moderna vaccine for emergency use – World Health Organization

---

OMS está perto de aprovar as vacinas dos laboratórios chineses Sinopharm e Sinovac

4 Mai, 2021 | 10:07h

WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines – Health Policy Watch

---

Guia prático para o uso de anticoagulantes orais não antagonistas de vitamina K em pacientes com fibrilação atrial

4 Mai, 2021 | 09:45h

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation – EP Europace

Comentário: EHRA Updates Its Popular ‘Practical’ NOAC Guide – TCTMD

---

Estudo: Cefazolina é segura para a maioria dos pacientes que desenvolvem reação de hipersensibilidade não mediada por IgE à nafcilina

4 Mai, 2021 | 09:44h

Tolerability of Cefazolin in Nafcillin-Intolerant Patients for the Treatment of Methicillin-Susceptible Staphylococcus aureus Infections – Clinical Infectious Diseases

Relacionado: Systematic Review and Meta-analysis of the Safety of Antistaphylococcal Penicillins Compared to Cefazolin – Antimicrobial Agents & Chemotherapy

 

Comentário no Twitter

New case series found 90% tolerated switching to cefazolin out of 80 patients who experienced non-IgE hypersensitivity reactions to nafcillin.https://t.co/YbFeWS4n4k
Our previous metas-analysis https://t.co/sJBjrx4a3r found higher odds of these reactions with nafcillin. pic.twitter.com/SIWcSuPcct

— Antibiotic Tweets 🦠 (@khalideljaaly) April 28, 2021

 

---